“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

WASHINGTON, DC – When billionaires are in the spotlight for their oversized influence in Washington, especially in the Trump administration, comes this news: Vivek Ramaswamy’s wealth has soared even ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced the appointment of Maykin Ho, Ph.D., to its board of directors, and the promotions of Nathan ...

Greenlight Capital's David Einhorn has been vocal about his concerns around artificial intelligence driving overvaluation in ...

Union Minister of Science and Technology, Jitendra Singh, unveiled the Biotechnology Industry Research Assistance Council-Research, Development and Innovation (BIRAC-RDI) Fund aimed at enhancing ...

Heavyweight European venture capital firms like Novo Holdings and Sofinnova Partners have joined together to make the case for more urgently needed funding in the continent's biotech ecosystem. The ...

AP Biology students at Chelsea High School conducted a hands-on lab experiment using professional-grade biotech equipment through the Amgen Foundation’s Amgen Biotech Experience (ABE), joined by State ...

Women make up 56% of the life sciences workforce, yet the gender parity is skewed as they remain underrepresented at leadership roles. While barriers to opportunities remain, women continue to make a ...

Gilead Sciences GILD0.19%increase; green up pointing triangle logged higher profit in its latest quarter, boosted by sales growth for its HIV and liver disease treatments. The biopharmaceutical ...